Brudnick Richard 4
4 · Prime Medicine, Inc. · Filed May 21, 2024
Insider Transaction Report
Form 4
Brudnick Richard
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2024-05-17+19,300→ 38,600 totalExercise: $7.96Exp: 2032-08-04→ Common Stock (19,300 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on August 4, 2022, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 17, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 19,300 shares.